Speaker Profile

Dr Stephen Chambers

Company NameImperial College London

About

Dr.Stephen Chambers is CEO at SynbiCITE, the Innovation and Knowledge Centre for Synthetic Biology, with the mission to accelerate and promote the commercial exploitation of synthetic biology research and technology in the UK. Dr. Chambers brings over 20 years of biotechnology and entrepreneurial experience.

Previously, he was a founding scientist and Director of Gene Expression at Vertex Pharmaceuticals working on a number of drug discovery and development programmes, including the FDA approved drugs: Agenerase & Lexiva.

Later he co-founded Abpro, where he served as Vice President of Technology. Dr. Chambers has co-authored over 30 peer-reviewed publications and has a number of patents issued. 

Dr. Chambers also leads the teaching faculty for the entrepreneurial training programme: the Lean LaunchPad for Synthetic Biology at Imperial College London.

 

Conference Sessions

  • 26 Oct 2017, 10:40 - 11:00, Grange Tower Bridge Hotel

    Synthetic biology is a term now being used in personal care. It is an emerging field that applies engineering principles to the fundamental components of biolog...

    • Language: English

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.